|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 14/51 | (2006.01) | ||
| A61K 38/10 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C12N 15/63 | (2006.01) |
| (11) | Patento numeris | 2298800 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10014361.9 |
| Europos patento paraiškos padavimo data | 2006-04-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-03-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-11-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 677583 P | 2005-05-03 | US | |
| 776847 P | 2006-02-24 | US | |
| 782244 P | 2006-03-13 | US | |
| 792645 P | 2006-04-17 | US | |
| 410540 | 2006-04-25 | US |
| (72) |
Lu, Hsieng Sen, US
Paszty, Christopher, US
Robinson, Martyn Kim, GB
Henry, Alistair James, GB
Hoffmann, Kelly Sue, US
Latham, John, US
Lawson, Alastair, GB
Winkler, David, US
Winters, Aaron George, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | Sclerostin binding antibodies |
| Sclerostin binding antibodies |